PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Building a better malaria vaccine: Mixing the right cocktail

2013-12-27
(Press-News.org) Contact information: Sheetij Dutta
Sheetij.dutta.civ@mail.mil
301-319-9154
Public Library of Science
Building a better malaria vaccine: Mixing the right cocktail

A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26 in PLOS Pathogens suggest how a leading vaccine candidate could be vastly improved.

The study, led by Sheetij Dutta, from the Walter Reed Army Institute of Research, USA, and colleagues, focused on a protein called AMA1 needed by the Plasmodium falciparum parasite to invade blood cells and cause disease. Study results suggest that a cocktail of AMA1 proteins from only a few different strains can overcome major limitations of an earlier designed version of AMA1-based vaccines.

The challenge with the malaria parasite in general and its AMA1 surface protein in particular is that both exist as multiple strains. Using AMA1 in a vaccine readies the human immune system for subsequent encounters with the parasite, but when such a vaccine was previously tested in humans, it was effective mostly against one particular P. falciparum strain. To explore the potential for a more broadly protective vaccine, the scientists tested different cocktails of AMA1 from different parasite strains for their ability to elicit a diverse range of antibodies that are active in parasite inhibition assays. They confirmed that a cocktail of AMA1 proteins from three different parasite strains was better than one or two, and one they call Quadvax, which contained AMA1 proteins derived from four different strains, led to an antibody response that was broader than the sum of strain-specific antibodies elicited by the four individual strains. Moreover, Quadvax-elicited antibodies inhibited a range of parasites, including many strains that were different from those in the Quadvax mix. In different laboratory tests, Quadvax-induced antibodies inhibited the growth of 26 different parasite strains, and the scientists suggest that "the combination of four AMA1 variants in Quadvax may be sufficient to overcome global AMA1 diversity".

Besides varying a lot from strain to strain, AMA1 also contains less variable (conserved) exposed parts (so-called epitopes) on its surface. The researchers found that vaccination with Quadvax yielded not only antibodies against the variable epitopes, but also against more conserved epitopes of the AMA1 protein. Such antibodies were not seen when using individual strains for immunization, but Quadvax appeared to enhance the immunogenicity—the ability to provoke an antibody response—of these conserved parts of the protein. Since the epitopes are identical across strains, the resulting antibodies are broadly active rather than strain-specific.

The scientists conclude "we had set out to study broadening of antibody responses achieved by mixing AMA1 proteins and were surprised and delighted to find not only greater variety of strain-specific antibodies but also increased antibodies against conserved epitopes were induced by the Quadvax. Perhaps even more exciting, when mixed, combinations of these antibodies were synergistic in their broad inhibition of many parasite strains. Novel conserved epitopes described here can be targets for further improvement of the vaccine. Most importantly, our data strongly supports continued efforts to develop a blood stage vaccine against malaria".

In spite of the extreme variability, a vaccine containing only a few diverse AMA1 strains, the scientists hope, could provide universal coverage by redirecting the immune response towards conserved epitopes. The next steps will be to test human-use formulations of Quadvax in primate models and in a human blood-stage challenge model.



INFORMATION:

Funding: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding for the WRAIR and La Trobe University was provided by PATH Malaria Vaccine Initiative and US Agency for International Development Malaria Vaccine Program. Burnet Institute was funded by Institute National Health and Medical Research Council of Australia; Australian Research Council; and a Victorian State Government Operational Infrastructure Support grant. The NIH studies were supported in part by the Intramural Program of NIAID and the PATH Malaria Vaccine Initiative.

Competing Interests: SD has been named on an AMA1 related US patent. This does not alter our adherence to all PLOS policies on sharing data and materials.

Citation: Dutta S, Dlugosz LS, Drew DR, Ge X, Ababacar D, et al. (2013) Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1. PLoS Pathog 9(12): e1003840. doi:10.1371/journal.ppat.1003840



ELSE PRESS RELEASES FROM THIS DATE:

Gene therapy for human skin disease produces long-term benefits

2013-12-27
Gene therapy for human skin disease produces long-term benefits Stem cell-based gene therapy holds promise for the treatment of devastating genetic skin diseases, but the long-term clinical outcomes of this approach have been unclear. In a study online December 26th in the ...

The fate of the eels

2013-12-27
The fate of the eels GEOMAR scientists prove oceanographic influences on eel recruitment Smoked, fried or boiled - the European eel (Anguilla anguilla) has always been a popular fish in Europe. Even though people have consumed it for millennia, the origin ...

Are concussions related to Alzheimer's disease?

2013-12-27
Are concussions related to Alzheimer's disease? MINNEAPOLIS – A new study suggests that a history of concussion involving at least a momentary loss of consciousness may be related to the buildup of Alzheimer's-associated plaques in the brain. The research ...

Surgery beats chemotherapy for tongue cancer, U-M study finds

2013-12-27
Surgery beats chemotherapy for tongue cancer, U-M study finds ANN ARBOR, Mich. — Patients with tongue cancer who started their treatment with a course of chemotherapy fared significantly worse than patients who received surgery first, according ...

Researchers point to digital gains in human recognition

2013-12-27
Researchers point to digital gains in human recognition Human beings are highly efficient at recognising familiar faces, even from very poor quality images. New research led by a psychologist at the University of York is using advances in the level of detail ...

Environmental fiscal reform would improve the environment and reduce the informal economy

2013-12-27
Environmental fiscal reform would improve the environment and reduce the informal economy Researchers at the UPV/EHU-University of the Basque Country and the BC3 (Basque Centre for Climate Change) are proposing measures to improve the environment and the efficiency of ...

New drug candidates show promise for cure for Chagas disease

2013-12-27
New drug candidates show promise for cure for Chagas disease A team of researchers from Canada has developed a class of compounds which may help eradicate a neglected tropical disease that is currently hard to kill in its chronic form. The research was published ...

What does compassion sound like?

2013-12-27
What does compassion sound like? "Good to see you. I'm sorry. It sounds like you've had a tough, tough, week." Spoken by a doctor to a cancer patient, that statement is an example of compassionate behavior observed by a University of Rochester ...

Rock And Rho: Proteins that help cancer cells groove

2013-12-27
Rock And Rho: Proteins that help cancer cells groove Cells' adaptations to low oxygen conditions inside tumors promote breast cancer's spread Biologists at The Johns Hopkins University have discovered that low oxygen conditions, which often persist inside tumors, ...

UTSW study identifies potential therapeutic target for incurable, rare type of soft-tissue cancer

2013-12-27
UTSW study identifies potential therapeutic target for incurable, rare type of soft-tissue cancer DALLAS – Dec. 26, 2013 – A deadly, rare type of soft-tissue cancer may be completely eradicated simply by inhibiting a key protein involved ...

LAST 30 PRESS RELEASES:

Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

US faces rising death toll from wildfire smoke, study finds

Scenario projections of COVID-19 burden in the US, 2024-2025

Disparities by race and ethnicity in percutaneous coronary intervention

Glioblastoma cells “unstick” from their neighbors to become more deadly

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

New light on toxicity of Bluefin tuna

Menopause drug reduces hot flashes by more than 70%, international clinical trial finds

FGF21 muscle hormone associated with slow ALS progression and extended survival

Hitting the right note: The healing power of music therapy in the cardiac ICU

Cardiovascular disease risk rises in Mexico, despite improved cholesterol control

Flexible optical touch sensor simultaneously pinpoints pressure strength and location

Achalasia diagnosis simplified to AI plus X-ray

PolyU scholars pioneer smart and sustainable personal cooling technologies to address global extreme heat

NIH grant aims for childhood vaccine against HIV

Menstrual cycle and long COVID: A relation confirmed

WMO report on global water resources: 2024 was characterized by both extreme drought and intense rainfall

New findings explain how a mutation in a cancer-related gen causes pulmonary fibrosis

Thermal trigger

[Press-News.org] Building a better malaria vaccine: Mixing the right cocktail